Glenmark Pharmaceuticals Q4 Results: Net dips 26% to Rs 173 cr
Glenmark Pharmaceuticals on Saturday said its consolidated profit after tax declined 26 per cent to Rs 173 crore for the fourth quarter ended March 31, 2022. The company had reported a profit after tax (PAT) of Rs 234 crore…